n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Brain Neoplasms in 6 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Notably, co-treatment of C6 glioma cells with 400 µmol/l NaHS and AOAA (an inhibitor of CBS) largely suppressed the above NaHS-induced effects." | 5.42 | Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways. ( Chen, J; Feng, J; Guo, R; He, J; Liu, C; Lu, Y; Zhang, W; Zhang, Y; Zhen, Y, 2015) |
| "Notably, co-treatment of C6 glioma cells with 400 µmol/l NaHS and AOAA (an inhibitor of CBS) largely suppressed the above NaHS-induced effects." | 1.42 | Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways. ( Chen, J; Feng, J; Guo, R; He, J; Liu, C; Lu, Y; Zhang, W; Zhang, Y; Zhen, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardi, F | 1 |
| Augello, FR | 1 |
| Artone, S | 1 |
| Gugu, MK | 1 |
| Cifone, MG | 1 |
| Cinque, B | 1 |
| Palumbo, P | 1 |
| Zhen, Y | 1 |
| Zhang, W | 1 |
| Liu, C | 1 |
| He, J | 1 |
| Lu, Y | 1 |
| Guo, R | 1 |
| Feng, J | 1 |
| Zhang, Y | 1 |
| Chen, J | 1 |
| Matsuo, M | 1 |
| Yoshida, N | 1 |
| Zaitsu, M | 1 |
| Ishii, K | 1 |
| Hamasaki, Y | 1 |
| Obara, S | 1 |
| Nakata, M | 1 |
| Takeshima, H | 1 |
| Katagiri, H | 1 |
| Asano, T | 1 |
| Oka, Y | 1 |
| Maruyama, I | 1 |
| Kuratsu, J | 1 |
| Denkins, Y | 1 |
| Kempf, D | 1 |
| Ferniz, M | 1 |
| Nileshwar, S | 1 |
| Marchetti, D | 1 |
| Joki, T | 1 |
| Heese, O | 1 |
| Nikas, DC | 1 |
| Bello, L | 1 |
| Zhang, J | 1 |
| Kraeft, SK | 1 |
| Seyfried, NT | 1 |
| Abe, T | 1 |
| Chen, LB | 1 |
| Carroll, RS | 1 |
| Black, PM | 1 |
6 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Brain Neoplasms
| Article | Year |
|---|---|
Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
Topics: Antineoplastic Agents, Alkylating; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Cell Proliferati | 2022 |
Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways.
Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclo | 2015 |
Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.
Topics: Animals; Brain Neoplasms; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygena | 2004 |
Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398.
Topics: Brain; Brain Neoplasms; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase | 2004 |
Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Cyclooxygenase 2; D | 2005 |
Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Topics: Adult; Animals; Apoptosis; Astrocytoma; Brain; Brain Neoplasms; Cell Division; Cell Movement; Cocult | 2000 |